Is Malaysia Ready for Human Gene Editing: A Regulatory, Biosafety and Biosecurity Perspective
Open Access
- 11 March 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 9
Abstract
Gene editing platforms have revolutionized the field of genetics with a direct impact on the public health system. Although there are apparent benefits, it is often accompanied by public debates over its uncertainties and risks. In the Malaysian context, modern biotechnology has raised questions about how to best govern gene editing in regulations, biosafety, and biosecurity. Even though standards and guidelines on stem cell and cell-based therapies have been developed, there are no appropriate legal frameworks available for gene editing yet. Nevertheless, biosafety regulations were established to balance promoting biotechnology and protecting against their potential environmental and human health risks. There is also a need to address the potential of genetically modified organisms (GMOs) as bioweapons. Numerous frameworks from several international organizations may provide valuable input in formulating documents on gene editing. By establishing comprehensive guidelines, legal policies, and standards to tackle the challenges and risks associated with gene editing, Malaysia can successfully apply this modern technology in this country.Keywords
Funding Information
- Universiti Sains Malaysia
- Ministry of Higher Education, Malaysia
This publication has 64 references indexed in Scilit:
- A CRISPR way to engineer the human genomeGenome Biology, 2013
- Genetically modified mosquito: The Malaysian public engagement experienceBiotechnology Journal, 2012
- Open Field Release of Genetically Engineered Sterile Male Aedes aegypti in MalaysiaPLOS ONE, 2012
- Biosafety Act 2007: Does It Really Protect Bioethical Issues Relating To GMOSJournal of Agricultural and Environmental Ethics, 2012
- Health care delivery in Malaysia: changes, challenges and championsJournal of Public Health in Africa, 2011
- Awareness of Modern Biotechnology and Media CoverageResearch Journal of Applied Sciences, 2011
- Asilomar 1975: DNA modification securedNature, 2008
- As Gelsinger Case Ends, Gene Therapy Suffers Another BlowScience, 2005
- Harm, ethics committees and the gene therapy deathJournal of Medical Ethics, 2001
- Asilomar Revisited: Lessons for Today?Science, 2000